Bioresorbable polymeric vascular scaffolds a cautionary tale1

Circulation: Cardiovascular Interventions

Volumn 4, Issue 5, 2011, Pages 535-538

  Ormiston, John A ^a,b   De Vroey, Frederic ^a   Serruys, Patrick W ^c   Webster, Mark W I ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Mercy Hospital   (New Zealand)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; MOLECULAR SCAFFOLD;

AGED; ANGINA PECTORIS; BIORESORBABLE VASCULAR SCAFFOLD; CASE REPORT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

AGED; ANGINA PECTORIS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; HUMANS; MALE; POLYMERS; PROSTHESIS FAILURE; PROSTHESIS RETENTION; SIROLIMUS; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 82955229532     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.963710     Document Type: Note

References (3)

1. Ormiston J, Serruys PW, Regar E, Dudek D, Thuesen L, Webster M, Onuma Y, Garcia-Garcia H, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008;371:899-907. (Pubitemid 351384734)
2. Serruys PW, Ormiston J, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia H, Nieman K, Bruining N, Dorange C, Miquel-Herbert K, Veldhof S, Webster M, Thuesen L, Dudek D. Absorb Trial first-in-man evaluation of a bioabsorbable Everolimus-eluting coronary stent system: two-year outcomes and results from multiple imaging modalities. Lancet. 2009;373:897-910.
3. Serruys P, Onuma Y, Ormiston J, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miguel-Herbert K, Rapoza R, Garcia-Garcia H. Evaluation of the second generation of a Bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122:2301-2312.